文献速递乳腺MR

乳腺癌:MRI肿瘤体积估算方法对新辅助化疗后病理反应预测的影响

Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy.
PubMed 文献 · Br J Radiol · 2018-05-02

研究纳入136例经活检证实乳腺癌并接受新辅助化疗(NAC)的女性,在基线和第3周期后行动态增强MRI,比较自动推导的功能性肿瘤体积(FTV)与半自动阈值法获得的强化肿瘤体积(ETV)的百分比变化对术后残余癌负荷(RCB)评分的预测能力。ETV变化识别病理完全缓解(pCR)的AUC为0.920,优于FTV的0.834;作者认为ETV变化可识别可能达到完全缓解的患者,并可能影响是否避免NAC后手术的管理决策。

要点

  • ETV变化识别pCR的AUC为0.920,敏感度81.0%、特异度91.8%,优于FTV的AUC 0.834。
  • FTV仅能区分pCR与RCB-II/RCB-III(p<0.040),ETV可区分pCR与RCB-I/II/III(p<0.006)。
  • 作者认为中期ETV变化比FTV更有助于预测NAC最终病理反应。

核心结论

  • ETV变化可识别可能达到NAC完全缓解的患者,并可能影响关于避免NAC后手术的患者管理决策;中期ETV变化在预测最终病理反应方面比FTV更有用。

研究设计与样本

  • 研究纳入136例经活检证实乳腺癌并计划在NAC期间行MRI监测的女性,于基线(NAC前)和第3周期NAC后采集动态增强图像,计算FTV(厂商软件自动推导)和ETV(半自动阈值技术用户推导)及其百分比变化,以手术切除标本的RCB评分评估反应并进行统计学比较和ROC分析。

诊断标准与关键数值

  • 各RCB反应类别的平均体积变化(FTV/ETV):pCR 95.5%/96.8%,RCB-I 69.8%/66.7%,RCB-II 64.0%/65.5%,RCB-III 25.4%/24.0%;FTV在pCR与RCB-II/RCB-III间差异显著(p<0.040,非配对t检验),ETV在pCR与RCB-I/RCB-II/RCB-III间差异显著(p<0.006,非配对t检验)。NAC后识别pCR的ROC分析:FTV的AUC为0.834,ETV的AUC为0.920;FTV敏感度80.0%、特异度76.8%,ETV敏感度81.0%、特异度91.8%。

临床应用与阅片要点

  • 原文结论认为ETV变化可识别可能达到NAC完全缓解的患者,并可能影响关于避免NAC后手术的患者管理决策;作者指出中期ETV变化在预测最终病理反应方面比FTV更有用,且ETV能将将达到完全缓解的患者与将有残余疾病的患者区分开。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Does method of tumour volume measurement on MRI influence prediction of treatment outcome in patients with primary breast cancer undergoing neoadjuvant chemotherapy (NAC)?.

METHOD: The study comprised of 136 women with biopsy-proven breast cancer scheduled for MRI monitoring during NAC treatment. Dynamic contrast-enhanced images were acquired at baseline (pre-NAC) and interim (post three NAC cycles) time points. Functional tumour volumes (FTVs), automatically derived using vendor software and enhancing tumour volumes (ETVs), user-derived using a semi-automated thresholding technique, were calculated at each time point and percentage changes calculated. Response, assessed using residual cancer burden (RCB) score on surgically resected specimens, was compared statistically with volumetric changes and receiver operating characteristic analysis performed.

RESULTS: Mean volumetric differences for each RCB response category were (FTV/ETV): pathological complete response (pCR) 95.5/96.8%, RCB-I 69.8/66.7%, RCB-II 64.0/65.5%, RCB-III 25.4/24.0%. Differences were significant between pCR and RCB-II/RCB-III categories (p < 0.040; unpaired t-test) using FTV measures and between pCR and RCB-I/RCB-II/RCB-III categories (p < 0.006; unpaired t-test) when ETV was used. Receiver operating characteristic analysis for pCR identification post-NAC yielded area under the curve for FTV/ETV of 0.834/0.920 respectively. Sensitivity and specificity for FTV was 80.0 and 76.8% for FTV and 81.0 and 91.8% for ETV.

CONCLUSION: ETV changes can identify patients likely to achieve a complete response to NAC. Potentially, this could impact patient management regarding the possible avoidance of post-NAC surgery. Advances in Knowledge: Interim changes in ETV are more useful than FTV in predicting final pathological response to NAC. ETV differentiates patients who will achieve a complete response from those who will have residual disease.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Henderson SA, Muhammad Gowdh N, Purdie CA, et al. Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy. Br J Radiol. 2018. PMID: 29641224. doi:10.1259/bjr.20180123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。